Valerie Guild was Founder and President of the non-profit organization AIM at Melanoma, and served as a patient advocate on ECOG-ACRIN’s Melanoma Committee for over ten years.
De-escalation is an effort to reduce the intensity of treatment without sacrificing efficacy. This issue covers several de-escalation trials: DECREASE, CompassHER2 pCR, and E3311.
Advocate Gerald Green shares his perspective on how to anticipate the late effects of cancer—and its treatment. Late effects can appear months or even years after patients finished therapy.
Lynne Alston is a thought leader, entrepreneur, international best-selling author of A Hug Saved My Life™, cancer survivor and advocate, community ambassador, life and wellness coach, and the founder/chief executive officer of the HUGS Around America™ Foundation.